Avestar Capital, LLC Takeda Pharmaceutical CO LTD Transaction History

Avestar Capital, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 01, 2022	SELL	$13.17 - $16.4 $790,805 - $984,754	-60,046 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$16.3 - $17.26 $76,463 - $80,966	4,691 Added 8.47%	60,046 $984,000
Q2 2021 Aug 03, 2021	BUY	$16.55 - $18.64 $395,230 - $445,141	23,881 Added 75.88%	55,355 $932,000
Q1 2021 May 03, 2021	BUY	$16.71 - $19.9 $264,652 - $315,176	15,838 Added 101.29%	31,474 $528,000
Q4 2020 Feb 01, 2021	BUY	$15.39 - $18.97 $240,638 - $296,614	15,636 New	15,636 $285,000

Q3 2019 Nov 14, 2019	SELL	$16.15 - $17.99 $33,721 - $37,563	-2,088 Closed	0 $0
Q2 2019 Aug 06, 2019	SELL	$16.58 - $20.49 $3,780 - $4,671	-228 Reduced 9.84%	2,088 $35,000
Q1 2019 May 09, 2019	BUY	$16.7 - $21.52 $37,324 - $48,097	2,235 Added 2759.26%	2,316 $45,000
Q4 2018 Jan 25, 2019	BUY	$15.64 - $21.1 $1,266 - $1,709	81 New	81 $1,000

340

76.2M

1.85M

121K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $42B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Avestar Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Avestar Capital, LLC with notifications on news.